Ferghana防针刺伤型静脉留置针通过全程无针暴露的一体化设计，可以有效降低针刺伤风险，强化医护人员职业安全；新款3DMax疝修补补片采用全球首 创3D立体结构与解剖定位线，可以快速展开、无需固定，能提高手术效率并降低术后疼痛……碧迪医疗大中华区企业品牌公关及数智传播总监李莎向记 者介绍"进博号"上"载着"的产品。 第八届中国国际进口博览会（下称"进博会"）将于11月5日至10日在上海举办。中国证券报记者11月4日提前探访"四叶草"展馆时发现，在医疗器械及医药 保健展区内，碧迪医疗展位上体型颇大的"进博号"轮船模型引人注目，"舷窗"内摆放了多个全球首发、中国首发及限定首发新品。 包括碧迪医疗在内，本届进博会吸引了155个国家、地区和国际组织参与，4108家境外企业参展，整体展览面积超过43万平方米，规模再创新高，多项代 表性首发新产品、新技术、新服务在此发布。进博会正为世界"尖货"进入中国市场搭建"首秀场"。 "载有"多个首发产品的碧迪医疗"进博号" Marie®立式粒子治疗室内系统 汽车及智慧出行展区内，特斯拉Cybercab无人驾驶电动车亚太首秀，其以金色流线型车身、无方向盘和脚踏板的设计，展现特斯拉无 ...

Core Viewpoint - Fosun Pharma will showcase its innovative pharmaceutical products and high-end medical devices at the 8th China International Import Expo (CIIE), emphasizing its role as a global healthcare industry leader rooted in China [1][2]. Group 1: Company Achievements - Fosun Pharma has successfully transformed from an exhibitor to an investor, leveraging the CIIE to accelerate the localization of advanced technologies and innovative medical products in China [1]. - The company has introduced at least six innovative products, referred to as "CIIE babies," which have been successfully launched or approved in China, including the Da Vinci surgical robot and the CAR-T cell therapy product Yikaida® [2][3]. Group 2: Product Innovations - The Marie® vertical particle therapy system, a revolutionary breakthrough in tumor radiotherapy, has been highlighted for its compact design, reducing the required space from 120 square meters to 30 square meters, thus lowering construction and operational costs [2]. - Yikaida®, as China's first approved CAR-T product, has benefited over 1,000 lymphoma patients since its approval in 2021, showcasing the positive impact of the CIIE on global resource collaboration [3]. Group 3: Future Directions - Fosun Pharma aims to focus on industry upgrades and embrace innovative products in future CIIE participations, seeking to gather more global resources as a multinational enterprise [3].